InQpharm Group: Overweight trials

The registry lists 12 Overweight studies with InQpharm Group as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 3 4Phase 4 3No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of IQP-VV-102 in Weight ManagementCompletedNCT01681069Phase 3Results posted
• Litramine in Weight MaintenanceCompletedNCT01505387Phase 4Results posted
• Efficacy and Safety of Zenoctil in Reducing Body WeightCompletedNCT01423617Phase 3Results posted
• Benefit and Tolerability of IQP-LU-104 in Weight LossCompletedNCT03888911Not applicable
• Efficacy and Safety of Litramine in 1 Year Weight Loss StudyCompletedNCT03227276Not applicable
• Benefit and Tolerability of IQP-AE-103 in Weight LossCompletedNCT03058367Not applicable
• Efficacy of Glucosanol™ in Reducing Post-prandial Glucose Levels in Overweight SubjectsCompletedNCT02930681Not applicable
• Efficacy and Safety of Glucosanol™ in Body Weight ReductionCompletedNCT02930668Not applicable
• Benefit of IQP-VV-102 in Reducing Postprandial Glucose Level in Overweight Caucasian SubjectsCompletedNCT02541344Phase 3
• Efficacy and Safety of Glucosanol in Maintaining Body WeightCompletedNCT01435278Phase 4
• Safety and Efficacy of Glucosanol in Reducing Body Weight in Overweight and Obese SubjectsCompletedNCT01407393Phase 4
• Safety and Efficacy of Litramine in Overweight and Obese SubjectsCompletedNCT01233349Phase 3